Dudley & Shanley’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-251,196
| Closed | -$19.3M | – | 30 |
|
|
2022
Q2 | $19.3M | Sell |
251,196
-5,175
| -2% | -$398K | 4.33% | 13 |
|
|
2022
Q1 | $18.7M | Buy |
256,371
+160,130
| +166% | +$11.7M | 3.48% | 16 |
|
|
2021
Q4 | $6M | Sell |
96,241
-476,769
| -83% | -$29.7M | 1.04% | 22 |
|
|
2021
Q3 | $33.9M | Sell |
573,010
-21,990
| -4% | -$1.3M | 5.96% | 4 |
|
|
2021
Q2 | $39.8M | Buy |
595,000
+1,450
| +0.2% | +$96.9K | 6.56% | 2 |
|
|
2021
Q1 | $37.5M | Sell |
593,550
-6,340
| -1% | -$400K | 6.47% | 3 |
|
|
2020
Q4 | $37.2M | Buy |
599,890
+133,200
| +29% | +$8.26M | 6.85% | 2 |
|
|
2020
Q3 | $28.1M | Buy |
466,690
+83,100
| +22% | +$5.01M | 6.83% | 5 |
|
|
2020
Q2 | $22.6M | Sell |
383,590
-96,400
| -20% | -$5.67M | 6.24% | 9 |
|
|
2020
Q1 | $26.8M | Buy |
479,990
+157,115
| +49% | +$8.76M | 6.72% | 3 |
|
|
2019
Q4 | $20.7M | Buy |
+322,875
| New | +$20.7M | 4.67% | 12 |
|